Skip to main content
Clinical Trials/JPRN-jRCT1080220914
JPRN-jRCT1080220914
Unknown
未知

A prospective observational study of the efficacy and safety of CPT-11 based regimens (CPT-11+platinum analogues) for UGT1A1 genotype guided patients

DAIICHI SANKYO COMPANY, LIMITED0 sites1,000 target enrollmentNovember 10, 2009

Overview

Phase
未知
Intervention
Not specified
Conditions
Small cell lung cancer, non-small cell lung cancer, cervical cancer, ovarian cancer and gastric cancer (inoperable or recurrent)
Sponsor
DAIICHI SANKYO COMPANY, LIMITED
Enrollment
1000
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 10, 2009
End Date
TBD
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Small cell lung cancer, non\-small cell lung cancer, cervical cancer, ovarian cancer and gastric cancer
  • 2\. Patients to receiving CPT\-11 plus platinum anolaogues regimens
  • Age requirement none

Exclusion Criteria

  • 1\. Contraindications of CPT\-11
  • 2\. ECOG PS 3\-4

Outcomes

Primary Outcomes

Not specified

Similar Trials